sirolimus and Metabolism--Inborn-Errors

sirolimus has been researched along with Metabolism--Inborn-Errors* in 1 studies

Other Studies

1 other study(ies) available for sirolimus and Metabolism--Inborn-Errors

ArticleYear
Loss of cardiac carnitine palmitoyltransferase 2 results in rapamycin-resistant, acetylation-independent hypertrophy.
    The Journal of biological chemistry, 2017, 11-10, Volume: 292, Issue:45

    Cardiac hypertrophy is closely linked to impaired fatty acid oxidation, but the molecular basis of this link is unclear. Here, we investigated the loss of an obligate enzyme in mitochondrial long-chain fatty acid oxidation, carnitine palmitoyltransferase 2 (CPT2), on muscle and heart structure, function, and molecular signatures in a muscle- and heart-specific CPT2-deficient mouse (Cpt2

    Topics: Acetylation; Animals; Atrial Remodeling; Cardiomegaly; Carnitine O-Palmitoyltransferase; Crosses, Genetic; Diet, Ketogenic; Drug Resistance; Enzyme Activation; Heart; Histone Deacetylase Inhibitors; Male; Mechanistic Target of Rapamycin Complex 1; Metabolism, Inborn Errors; Mice, Knockout; Mice, Transgenic; Mitochondria, Heart; Myocardium; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Sirolimus; Specific Pathogen-Free Organisms; Survival Analysis

2017